Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00330083 · ClinicalTrials.gov registry record · Phase 1
Safety of ALK Ragweed Tablet
A Phase 1 study, sponsored by ALK-Abelló A/S.
- Completed
- Registry status
- Phase 1
- Development phase
- 72
- Enrollment target
NCT00330083 is a Phase 1 study that has completed, run by ALK-Abelló A/S. The registered enrollment target is 72 participants.
The verdict
NCT00330083, a Phase 1 study, has completed, sponsored by ALK-Abelló A/S.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 72 participants
- Enrollment target
Study Summary
This trial is performed to assess whether ALK Ragweed Tablet is safe to use in adults
Interventions
- BIOLOGICAL ALK Ragweed Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2006-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00330083
The ClinicalTrials.gov registry entry for NCT00330083 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ALK-Abelló A/S, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ALK Ragweed Tablet is the first listed.
NCT00330083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00330083 about?
NCT00330083 is a clinical study titled "Safety of ALK Ragweed Tablet". This trial is performed to assess whether ALK Ragweed Tablet is safe to use in adults
What is the current status of trial NCT00330083?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2006-05.
What interventions are being tested in trial NCT00330083?
The interventions under investigation include: ALK Ragweed Tablet (BIOLOGICAL).
Who is sponsoring clinical trial NCT00330083?
This trial is sponsored by ALK-Abelló A/S, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.